Clinical Research Directory
Browse clinical research sites, groups, and studies.
Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
Sponsor: M.D. Anderson Cancer Center
Summary
This clinical trial investigates the effects of switching from smoking regular cigarettes to electronic cigarettes (e-cigarettes) among older adult smokers at high risk for lung cancer. E-cigarettes use heated vapor to deliver nicotine. Information gained from this trial may help inform regulators of the potential risks and benefits of switching smokers at high risk for lung cancer to electronic cigarettes. This research also may help inform the Food and Drug Administration (FDA) how best to regulate e-cigarettes with the goal of improving public health.
Official title: The Potential Risks and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
Key Details
Gender
All
Age Range
50 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2022-03-07
Completion Date
2026-10-17
Last Updated
2026-03-02
Healthy Volunteers
Yes
Conditions
Interventions
Participants smoke their usual brand of cigarettes for 26 weeks.
Participants smoke their usual brand of cigarettes for 26 weeks.
Participants will vape electronic cigarettes for 26 weeks.
Participants will vape electronic cigarettes for 26 weeks.
Nicotine Replacement
Smoke usual brand of cigarettes
Nicotine Replacement
Vape e-cigarettes
Questionnaire Administration
Use smartphone to answer questions about nicotine cravings and mood, and log daily smoking activity every day.
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States